BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
FOXP1
,
T cell differentiation
,
Lung cancer
,
Pancreas
,
DNA fingerprint
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CDX-3
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Colon
Ascending colon
Sigmoid colon
Transverse colon
Rectum colon
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
CDX2 Is a Prognostic Biomarker for Unresectable Metastatic Colorectal Cancer.
Further prognostic stratification of intestinal type of gastric adenocarcinoma by CDX2 expression pa…
Potential predictors for CDX2 expression loss and mismatch repair deficiency in colorectal cancer.
Pattern of expression of CDX2 in colorectal cancer and its role in prognosis.
CDX2 expression in primary skin tumors-case series and review of the literature.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unre…
NeoVax + CDX-301 and Nivolumab in Melanoma
A Study of CDX-0159 in Patients With Prurigo Nodularis
Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ